Commerce Bank Gilead Sciences, Inc. Transaction History

Commerce Bank

$15.3 Billion
Q2 2024

A detailed history of Commerce Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Commerce Bank holds 65,439 shares of GILD stock, worth $5.54 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

65,439

Previous 66,252 1.23%

Holding current value

$5.54 Million

Previous $4.85 Million 7.48%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $51,340 - $59,251	-813 Reduced 1.23%	65,439 $4.49 Million
Q1 2024 May 03, 2024	BUY	$71.58 - $87.29 $145,593 - $177,547	2,034 Added 3.17%	66,252 $4.85 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $14,873 - $16,867	203 Added 0.32%	64,218 $5.2 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $21,442 - $23,394	-290 Reduced 0.45%	64,015 $4.8 Million
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $123,212 - $140,540	-1,621 Reduced 2.46%	64,305 $4.96 Million
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $2,087 - $2,378	27 Added 0.04%	65,926 $5.47 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $26,049 - $37,398	-418 Reduced 0.63%	65,899 $5.66 Million
Q3 2022 Nov 04, 2022	SELL	$59.54 - $68.01 $10,062 - $11,493	-169 Reduced 0.25%	66,317 $4.09 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $28,225 - $31,789	-489 Reduced 0.73%	66,486 $4.11 Million
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $1.18 Million - $1.48 Million	-20,408 Reduced 23.35%	66,975 $3.98 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $206,837 - $234,764	3,188 Added 3.79%	87,383 $6.35 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $457,110 - $493,171	6,753 Added 8.72%	84,195 $5.88 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $404,684 - $442,175	6,376 Added 8.97%	77,442 $5.33 Million
Q1 2021 May 05, 2021	SELL	$60.0 - $68.46 $152,820 - $174,367	-2,547 Reduced 3.46%	71,066 $4.59 Million
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $136,356 - $155,371	-2,407 Reduced 3.17%	73,613 $4.29 Million
Q3 2020 Nov 06, 2020	BUY	$62.1 - $78.08 $440,413 - $553,743	7,092 Added 10.29%	76,020 $4.8 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $8.36 Million - $9.71 Million	-115,588 Reduced 62.64%	68,928 $5.3 Million
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $270,937 - $347,031	4,326 Added 2.4%	184,516 $13.8 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $514,650 - $566,098	8,352 Added 4.86%	180,190 $11.7 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $5.06 Million - $5.58 Million	80,927 Added 89.02%	171,838 $10.9 Million
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $307,803 - $345,165	4,975 Added 5.79%	90,911 $6.14 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $32,640 - $36,566	-522 Reduced 0.6%	85,936 $5.59 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $199,237 - $259,989	3,291 Added 3.96%	86,458 $5.41 Million
Q3 2018 Nov 02, 2018	BUY	$71.28 - $78.92 $2.06 Million - $2.28 Million	28,848 Added 53.11%	83,167 $6.42 Million
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $42,236 - $49,267	-651 Reduced 1.18%	54,319 $3.85 Million
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $55,431 - $67,576	761 Added 1.4%	54,970 $4.14 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $150,482 - $176,644	2,115 Added 4.06%	54,209 $3.88 Million
Q3 2017 Nov 07, 2017	SELL	$72.11 - $85.47 $124,173 - $147,179	-1,722 Reduced 3.2%	52,094 $3.69 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $3.88 Million - $4.6 Million	53,816	53,816 $4.36 Million

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account